NASDAQ:RWLKRewalk Robotics Stock Price, Forecast & News

Rewalk Robotics' stock was trading at $0.6050 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RWLK shares have increased by 111.6% and is now trading at $1.28. View which stocks have been most impacted by Coronavirus.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rewalk Robotics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Rewalk Robotics.

Rewalk Robotics is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Rewalk Robotics.

Rewalk Robotics Ltd (NASDAQ:RWLK) issued its quarterly earnings data on Thursday, May, 28th. The medical device company reported ($0.37) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.26) by $0.11. The medical device company earned $0.76 million during the quarter, compared to analyst estimates of $2.20 million. Rewalk Robotics had a negative return on equity of 111.44% and a negative net margin of 379.84%. View Rewalk Robotics' earnings history.

1 brokers have issued 1-year target prices for Rewalk Robotics' stock. Their forecasts range from $3.50 to $3.50. On average, they anticipate Rewalk Robotics' stock price to reach $3.50 in the next year. This suggests a possible upside of 173.4% from the stock's current price. View analysts' price targets for Rewalk Robotics.

News articles about RWLK stock have been trending somewhat negative this week, InfoTrie reports. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rewalk Robotics earned a coverage optimism score of -1.2 on InfoTrie's scale. They also gave headlines about the medical device company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Rewalk Robotics.

Some companies that are related to Rewalk Robotics include ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Allied Healthcare Products (AHPI), Histogenics (HSGX), Precision Therapeutics (POAI), Ocugen (OCGN), NanoVibronix (NAOV), Bionik Laboratories (BNKL) and Avitar (AVTI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Rewalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners, L.P (CLMT), Two Harbors Investment (TWO), Novocure (NVCR), Blackrock Capital Investment (BKCC), Summit Midstream Partners (SMLP), Viper Energy Partners (VNOM), Washington Prime Group (WPG) and Roper Technologies (ROP).

Rewalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."

Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of RWLK stock can currently be purchased for approximately $1.28.

Rewalk Robotics has a market capitalization of $16.55 million and generates $4.87 million in revenue each year. The medical device company earns $-15,550,000.00 in net income (profit) each year or ($2.70) on an earnings per share basis. Rewalk Robotics employs 58 workers across the globe.

The official website for Rewalk Robotics is www.rewalk.com.

Rewalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected]